NATH BIOGENES (INDIA)
Back to Income Statement
|
NATH BIOGENES (INDIA) Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹315 Cr | ₹283 Cr | ₹252 Cr | ₹241 Cr | ₹118 Cr |
What is the latest Total Expenditure of NATH BIOGENES (INDIA) ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹315 Cr |
| Mar2024 | ₹283 Cr |
| Mar2023 | ₹252 Cr |
| Mar2022 | ₹241 Cr |
| Mar2013 | ₹118 Cr |
How is Total Expenditure of NATH BIOGENES (INDIA) Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹315 Cr | 11.42 | |
| Mar2024 | ₹283 Cr | 12.00 | |
| Mar2023 | ₹252 Cr | 4.66 | |
| Mar2022 | ₹241 Cr | 104.70 | |
| Mar2013 | ₹118 Cr | - | |
Compare Total Expenditure of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹295.2 Cr | -3.7% | -0.7% | -18.5% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹13,180.3 Cr | 1.6% | 2.8% | -11.5% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹5,071.9 Cr | 1.1% | -0.9% | 8.8% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,137.1 Cr | 2.6% | 10.7% | -18.1% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,108.9 Cr | -7.4% | 0.8% | -27.5% | Stock Analytics | |
| INDO US BIOTECH | ₹245.0 Cr | 1.1% | -2.8% | -54.1% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | -3.7% |
-0.7% |
-18.5% |
| SENSEX | -0.4% |
-0.6% |
8.6% |
You may also like the below Video Courses